In the PIV Notice, WhiteOak alleges that the claims of 19 EXPAREL patents listed in the FDA’s Orange Book (U.S. Patent Nos.11 ...

Hansoh Pharmaceutical Group Company Limited ( ($HK:3692) ) has shared an update. Hansoh Pharmaceutical Group Company Limited announced that its ...

The FDA has accepted Pharming Group’s supplemental new drug application for leniolisib in treating activated phosphoinositide ...

Blinatumomab, a new drug for childhood leukemia, has been a game-changer for young patients, allowing them to live more ...

The FDA accepted a new drug application for a single inhaler that contains beclomethasone dipropionate, formoterol fumarate ...

Once-daily Precision Timed Release™ (PTR™) stimulant designed to deliver rapid onset of effect and entire active-day duration ...

Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being ...

During his first term in office, President Trump’s FDA approved abortion pill manufacturer GenBioPro’s abbreviated new drug ...

Relacorilant targets glucocorticoid receptor proteins, potentially redefining treatment for platinum-resistant ovarian cancer by inhibiting cancer cell proliferation. Clinical trials show relacorilant ...

KANSAS CITY, Kan., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...

AbbVie is seeking a new way to fight chronic lymphocytic leukemia, or CLL, by combining its oncology drug Venclexta with another cancer-fighting drug. The North Chicago-based drugmaker has filed a ...

A rumor has circulated online since at least 2024 claiming that Japanese researchers have developed a drug that might help ...